Condensed benzazepine derivative and pharmaceutical composition thereof
    1.
    发明授权
    Condensed benzazepine derivative and pharmaceutical composition thereof 失效
    浓缩的苯并氮杂衍生物及其药物组合物

    公开(公告)号:US5723606A

    公开(公告)日:1998-03-03

    申请号:US586686

    申请日:1996-01-19

    摘要: This invention relates to nitrogen-containing aromatic 5-membered ring-condensed benzazepine derivatives represented by the general formula (I) ##STR1## (symbols in the formula have the following meanings; ring B: a nitrogen-containing aromatic 5-membered ring having at least 1 nitrogen atom and optionally one oxygen or sulfur atom, which may optionally have substituent(s), R.sup.1 and R.sup.2 : these may be the same or different from each other and each represents a hydrogen atom, a halogen atom, a lower alkyl group, an amino group which may optionally be substituted by lower alkyl group(s), or a lower alkoxy group, A: a single bond; a group represented by the formula --NHCO--(CR.sup.3 R.sup.4).sub.n --, n: 0 or an integer of from 1 to 3, R.sup.3 and R.sup.4 : these may be the same or different from each other and each represents a hydrogen atom, a lower alkyl group (provided that R.sup.3 and R.sup.4 may together form a lower alkylene group having 2 to 7 carbon atoms), and ring C: a benzene ring which may optionally have substituent(s)) and salts thereof; to pharmaceutical compositions which contain these compounds as an active ingredient and to intermediates which are useful in synthesizing these compounds. The compounds of this invention are useful as arginine vasopressin antagonists.

    摘要翻译: PCT No.PCT / JP94 / 01183 Sec。 371日期1996年1月19日 102(e)1996年1月19日PCT PCT 1994年7月19日PCT公布。 出版物WO95 / 03305 日本特开1995年2月2日本发明涉及以下通式(I)表示的含氮芳香族五元环稠合苯并氮杂衍生物: 环B:具有至少1个氮原子和任选的一个氧或硫原子的含氮芳族五元环,其可任选具有取代基,R 1和R 2:它们可以彼此相同或不同, 各自表示氢原子,卤素原子,低级烷基,可以被低级烷基取代的氨基或低级烷氧基,A:单键; 由式NHCO-(CR 3 R 4)n - ,n:0或1〜3的整数表示的基团,R 3和R 4可以相同或不同,表示氢原子,低级 烷基(条件是R3和R4可以一起形成具有2至7个碳原子的低级亚烷基)和环C:可任选具有取代基的苯环)及其盐; 涉及含有这些化合物作为活性成分的药物组合物和可用于合成这些化合物的中间体。 本发明的化合物可用作精氨酸加压素拮抗剂。

    Condensed benzazepine derivative and pharmaceutical composition thereof
    2.
    发明授权
    Condensed benzazepine derivative and pharmaceutical composition thereof 失效
    浓缩的苯并氮杂衍生物及其药物组合物

    公开(公告)号:US5856564A

    公开(公告)日:1999-01-05

    申请号:US972271

    申请日:1997-11-18

    摘要: This invention relates to nitrogen-containing aromatic 5-membered ring-condensed benzazepine derivatives represented by the general formula (I) ##STR1## (symbols in the formula have the following meanings; ring B: a nitrogen-containing aromatic 5-membered ring having at least 1 nitrogen atom and optionally one oxygen or sulfur atom, which may optionally have substituent(s), R.sup.1 and R.sup.2 : these may be the same or different from each other and each represents a hydrogen atom, a halogen atom, a lower alkyl group, an amino group which may optionally be substituted by lower alkyl group(s), or a lower alkoxy group,A: a single bond; a group represented by the formula --NHCO--(CR.sup.3 R.sup.4).sub.n --,n: 0 or an integer of from 1 to 3,R.sup.3 and R.sup.4 : these may be the same or different from each other and each represents a hydrogen atom, a lower alkyl group (provided that R.sup.3 and R.sup.4 may together form a lower alkylene group having 2 to 7 carbon atoms), andring C: a benzene ring which may optionally have substituent(s)) and salts thereof; to pharmaceutical compositions which contain these compounds as an active ingredient and to intermediates which are useful in synthesizing these compounds. The compounds of this invention are useful as arginine vasopressin antagonists.

    摘要翻译: 本发明涉及由通式(I)表示的含氮芳族五元环稠合苯并氮杂衍生物(I)(式中符号具有以下含义;环B:含氮芳族5- 具有至少1个氮原子和任选的一个氧或硫原子的多元环,其可以任选具有取代基,R 1和R 2:它们可以相同或不同,并且各自表示氢原子,卤素原子, 低级烷基,可以被低级烷基或低级烷氧基取代的氨基,A:单键;由式-NHCO-(CR 3 R 4)n表示的基团,n: 0或1〜3的整数,R3和R4:它们可以相同或不同,各自表示氢原子,低级烷基(条件是R3和R4可以一起形成具有2个的低级亚烷基 至7个碳原子)和环C:可以任选具有取代基的苯环 (s))及其盐; 涉及含有这些化合物作为活性成分的药物组合物和可用于合成这些化合物的中间体。 本发明的化合物可用作精氨酸加压素拮抗剂。

    Amidinonaphthyl derivative or salt thereof
    6.
    发明授权
    Amidinonaphthyl derivative or salt thereof 失效
    脒基萘基衍生物或其盐

    公开(公告)号:US5869501A

    公开(公告)日:1999-02-09

    申请号:US849391

    申请日:1997-05-30

    摘要: An amidinonaphthyl derivative represented by the following general formula (I) which has coagulation factor X inhibiting action and is useful as an anti-thrombus agent and the like, a salt thereof, an intermediate thereof and a pharmaceutical composition which comprises the amidinonaphthyl derivative. An amidinonaphthyl derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. ##STR1## (symbols in the formula have the following meanings; R.sup.1 : a hydrogen atom or a group represented by the formula --A--W--R.sup.4,A: a group represented by the formula ##STR2## a group represented by the formula ##STR3## or a group represented by the formula --SO.sub.2 --, X: an oxygen atom or a sulfur atom, W: a single bond or a group represented by the formula --NR.sup.5 --, R.sup.4 : a hydroxyl group, a lower alkoxy group, etc., R.sup.5 : a hydrogen atom, a carbamoyl group, a lower alkoxycarbonyl group, etc., R.sup.2 : a lower alkyl group, R.sup.3 : a hydrogen atom, a halogen atom, a carboxyl group, B: a lower alkylene group or a carbonyl group, and n: 0 or 1).

    摘要翻译: PCT No.PCT / JP95 / 02458 Sec。 371日期1997年5月30日 102(e)日期1997年5月30日PCT提交1995年12月1日PCT公布。 公开号WO96 / 16940 日期1996年6月6日由以下通式(I)表示的脒基萘基衍生物,其具有凝血因子X抑制作用,可用作抗血栓剂等,其盐,其中间体和药物组合物,其包含 脒基萘基衍生物。 由以下通式(I)表示的脒基萘基衍生物或其药学上可接受的盐。 (式中的符号具有以下含义:R 1:氢原子或式-AW-R4表示的基团,A:由式SO 2表示的基团,由式 X:氧原子或硫原子,W:单键或由式-NR5-表示的基团,R4表示羟基,低级烷氧基等,R5表示氢原子,氨基甲酰基, 低级烷氧基羰基等,R2:低级烷基,R3:氢原子,卤素原子,羧基,B:低级亚烷基或羰基,n:0或1)。

    Amphoteric water-soluble polymer dispersion and use thereof
    8.
    发明授权
    Amphoteric water-soluble polymer dispersion and use thereof 失效
    两性水溶性聚合物分散体及其用途

    公开(公告)号:US07250462B2

    公开(公告)日:2007-07-31

    申请号:US10480392

    申请日:2002-05-28

    IPC分类号: C08F2/16 C08L13/02 B01D21/01

    摘要: The invention relates to an amphoteric water-soluble polymer dispersion containing polymer particles with particle diameters of 100 μm or smaller and produced by dispersion-copolymerization of a monomer mixture comprising a methacrylate monomer containing a quaternary ammonium salt group, an acrylate monomer containing a quaternary ammonium salt group, an anionic monomer, and a (meth)acrylamide in respectively ratios specified in an aqueous salt solution in the presence of a polymer dispersant soluble in the aqueous salt solution and the invention also relates to a dewatering agent for organic sludge, a pretreatment agent or yield improver for paper making raw materials, and/or a drainage properties-enhancing agent using the amphoteric water-soluble polymer.

    摘要翻译: 本发明涉及含有粒径为100μm以下的聚合物粒子的两性水溶性聚合物分散体,其通过包含含有季铵盐基团的甲基丙烯酸酯单体,含有季铵的丙烯酸酯单体的单体混合物的分散共聚而制备 盐组,阴离子单体和(甲基)丙烯酰胺,分别在可溶于盐水溶液的聚合物分散剂存在下,在盐水溶液中规定的比例,本发明还涉及一种用于有机污泥的脱水剂,预处理 用于造纸原料的试剂或产率改进剂,和/或使用两性水溶性聚合物的排水性能增强剂。